Galectin-9 binds IgM-BCR to regulate B cell signaling von Cao, Anh, Alluqmani, Nouf, Buhari, Fatima Hifza Mohammed, Wasim, Laabiah, Smith, Logan K., Quaile, Andrew T., Shannon, Michael, Hakim, Zaki, Furmli, Hossai, Owen, Dylan M., Savchenko, Alexei, Treanor, Bebhinn

Volltext

Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy von Wedge, Marie-Eve, Jennings, Victoria A., Crupi, Mathieu J. F., Poutou, Joanna, Jamieson, Taylor, Pelin, Adrian, Pugliese, Giuseppe, de Souza, Christiano Tanese, Petryk, Julia, Laight, Brian J., Boileau, Meaghan, Taha, Zaid, Alluqmani, Nouf, McKay, Hayley E., Pikor, Larissa, Khan, Sarwat Tahsin, Azad, Taha, Rezaei, Reza, Austin, Bradley, He, Xiaohong, Mansfield, David, Rose, Elaine, Brown, Emily E. F., Crawford, Natalie, Alkayyal, Almohanad, Surendran, Abera, Singaravelu, Ragunath, Roy, Dominic G., Migneco, Gemma, McSweeney, Benjamin, Cottee, Mary Lynn, Jacobus, Egon J., Keller, Brian A., Yamaguchi, Takafumi N., Boutros, Paul C., Geoffrion, Michele, Rayner, Katey J., Chatterjee, Avijit, Auer, Rebecca C., Diallo, Jean-Simon, Gibbings, Derrick, tenOever, Benjamin R., Melcher, Alan, Bell, John C., Ilkow, Carolina S.

Volltext

Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy von Taha, Zaid, Crupi, Mathieu Joseph François, Alluqmani, Nouf, MacKenzie, Duncan, Vallati, Sydney, Whelan, Jack Timothy, Fareez, Faiha, Alwithenani, Akram, Petryk, Julia, Chen, Andrew, Spinelli, Marcus Mathew, Ng, Kristy, Sobh, Judy, de Souza, Christiano Tanese, Bharadwa, Priya Rose, Lee, Timothy Kit Hin, Thomas, Dylan Anthony, Huang, Ben Zhen, Kassas, Omar, Poutou, Joanna, Gilchrist, Victoria Heather, Boulton, Stephen, Thomson, Max, Marius, Ricardo, Hooshyar, Mohsen, McComb, Scott, Arulanandam, Rozanne, Ilkow, Carolina Solange, Bell, John Cameron, Diallo, Jean-Simon

Volltext

Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines von Alluqmani, Nouf, Jirovec, Anna, Taha, Zaid, Varette, Oliver, Chen, Andrew, Serrano, Daniel, Maznyi, Glib, Khan, Sarwat, Forbes, Nicole E, Arulanandam, Rozanne, Auer, Rebecca C, Diallo, Jean-Simon

Volltext

Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer von Crupi, Mathieu J. F., Taha, Zaid, Janssen, Thijs J. A., Petryk, Julia, Boulton, Stephen, Alluqmani, Nouf, Jirovec, Anna, Kassas, Omar, Khan, Sarwat T., Vallati, Sydney, Lee, Emily, Huang, Ben Zhen, Huh, Michael, Pikor, Larissa, He, Xiaohong, Marius, Ricardo, Austin, Bradley, Duong, Jessie, Pelin, Adrian, Neault, Serge, Azad, Taha, Breitbach, Caroline J., Stojdl, David F., Burgess, Michael F., McComb, Scott, Auer, Rebecca, Diallo, Jean-Simon, Ilkow, Carolina S., Bell, John Cameron

Volltext

Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus von Taha, Zaid, Crupi, Mathieu J F, Alluqmani, Nouf, Fareez, Faiha, Ng, Kristy, Sobh, Judy, Lee, Emily, Chen, Andrew, Thomson, Max, Spinelli, Marcus M, Ilkow, Carolina S, Bell, John C, Arulanandam, Rozanne, Diallo, Jean-Simon

Volltext

Dependency of EGFR activation in vanadium-based sensitization to oncolytic virotherapy von Wong, Boaz, Bergeron, Anabel, Alluqmani, Nouf, Maznyi, Glib, Chen, Andrew, Arulanandam, Rozanne, Diallo, Jean-Simon

Volltext

838 Oncolytic virus induced tumour-infiltrating lymphocytes (TILs) for the treatment of colorectal cancer von Vallati, Sydney, Crupi, Mathieu, Taha, Zaid, Petryk, Julia, Austin, Bradley, Gilchrist, Victoria, Alluqmani, Nouf, Boulton, Stephen, Bell, John

Volltext

CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX von Whelan, Jack T, Singaravelu, Ragunath, Wang, Fuan, Pelin, Adrian, Tamming, Levi A, Pugliese, Giuseppe, Martin, Nikolas T, Crupi, Mathieu J F, Petryk, Julia, Austin, Bradley, He, Xiaohong, Marius, Ricardo, Duong, Jessie, Jones, Carter, Fekete, Emily E F, Alluqmani, Nouf, Chen, Andrew, Boulton, Stephen, Huh, Michael S, Tang, Matt Y, Taha, Zaid, Scut, Elena, Diallo, Jean-Simon, Azad, Taha, Lichty, Brian D, Ilkow, Carolina S, Bell, John C

Volltext

A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection von Boulton, Stephen, Poutou, Joanna, Gill, Rida, Alluqmani, Nouf, He, Xiaohong, Singaravelu, Ragunath, Crupi, Mathieu J.F., Petryk, Julia, Austin, Bradley, Angka, Leonard, Taha, Zaid, Teo, Iris, Singh, Siddarth, Jamil, Rameen, Marius, Ricardo, Martin, Nikolas, Jamieson, Taylor, Azad, Taha, Diallo, Jean-Simon, Ilkow, Carolina S., Bell, John C.

Volltext

The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy von Arulanandam, Rozanne, Taha, Zaid, Garcia, Vanessa, Selman, Mohammed, Chen, Andrew, Varette, Oliver, Jirovec, Anna, Sutherland, Keara, Macdonald, Elizabeth, Tzelepis, Fanny, Birdi, Harsimrat, Alluqmani, Nouf, Landry, Anne, Bergeron, Anabel, Vanderhyden, Barbara, Diallo, Jean-Simon

Volltext

Impact of viral sensitizer-enhanced oncolytic virus immunotherapy on the anti-tumor immune response von Alluqmani, Nouf N., Bergeron, Anabel, Chen, Andrew, Khan, Sarwat, Forbes, Nicole, Arulanandam, Rozanne, Souza, Christiano, Crans, Debbi C., Diallo, Jean-Simon

Volltext

Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry von Azad, Taha, Singaravelu, Ragunath, Taha, Zaid, Jamieson, Taylor R., Boulton, Stephen, Crupi, Mathieu J.F., Martin, Nikolas T., Fekete, Emily E.F., Poutou, Joanna, Ghahremani, Mina, Pelin, Adrian, Nouri, Kazem, Rezaei, Reza, Marshall, Christopher Boyd, Enomoto, Masahiro, Arulanandam, Rozanne, Alluqmani, Nouf, Samson, Reuben, Gingras, Anne-Claude, Cameron, D. William, Greer, Peter A., Ilkow, Carolina S., Diallo, Jean-Simon, Bell, John C.

Volltext

Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen von Taha, Zaid, Arulanandam, Rozanne, Maznyi, Glib, Godbout, Elena, Carter-Timofte, Madalina E., Kurmasheva, Naziia, Reinert, Line S., Chen, Andrew, Crupi, Mathieu J.F., Boulton, Stephen, Laroche, Geneviève, Phan, Alexandra, Rezaei, Reza, Alluqmani, Nouf, Jirovec, Anna, Acal, Alexandra, Fekete, Emily E.F., Singaravelu, Ragunath, Petryk, Julia, Idorn, Manja, Potts, Kyle G., Todesco, Hayley, John, Cini, Mahoney, Douglas J., Ilkow, Carolina S., Giguère, Patrick, Alain, Tommy, Côté, Marceline, Paludan, Søren R., Olagnier, David, Bell, John C., Azad, Taha, Diallo, Jean-Simon

Volltext